Media & Advertising
Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
Have an interest in this Story?
Sign Up for Real-Time email updates
August 01, 2013
/PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and six months ended June 30, ...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Most Read Biotech Articles
Fuddruckers Deluxe Bar & Grill Marks Veterans Day; Active And Retired Military
Delta Gives Back to Veterans, Service Members and their Families with Matching SkyMiles
U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Mak…
- Asia PR News
House GOP's lawyers give up on anti-Obama...
Gardner Denver Acquires Garo Dott. Ing. Roberto Gabbioneta S.p.A.
- Channel 8 Eyewitness News
Sylvia M. Romagosa, MBA
Licensed Real Estate Broker
Real Estate Industry
Corporate Marketing Manager
View more profiles
Access dozens of premium and subscriptions sites
Build a News Circle
Get News Briefings
Congoo News Home
Get the Netpass
Copyright ©2014 Congoo.com. All Rights Reserved.